CAPITOL COUNSEL LLC for GENENTECH
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the 340B Drug Pricing Program; Issues related to repeal and replacement of the Affordable Care Act, including provisions in H.R. 1628, the American Health Care Act, and proposed Senate substitute amendments, including the Health Care Freedom Act and Senators Graham and Cassidy proposed block grant substitute amendment.
Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE ABRAMSON | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
| JAMES O MCCRERY | — |
Medicare/Medicaid MMM
Implementation of Medicare pharmaceutical coverage and reimbursement; Medicare Part B reimbursement for physicians, and related provisions of the Affordable Care Act. Medicare Part B drug reimbursement adequacy and patient access issues associated with potential CMMI implementation of the proposed Medicare Part B Drug Payment Model.
Foreign entity interest: Foreign parent affected by policies affecting U.S. subsidiary.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE ABRAMSON | — |
| SHANNON FINLEY | — |
| SARA FRANKO | — |
| DREW GOESL | — |
| MARTIN B. GOLD | — |
| LUKE HATZIS | — |
| DENISE HENRY MORRISEY | — |
| ANN JABLON | — |
| JAMES O MCCRERY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.